ADVERSE REACTIONS Generalized: Anaphylactic shock and death have been reported with administration of parenteral vitamin B 12
Tirzepatide is a dual-action medication known as a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist
They must go through the digestive system on the way to our lips and can be absorbed, which can limit their effectiveness
A small subset of patients has antibiotic-refractory chronic pouchitis and requires treatment with corticosteroids (eg, budesonide), immunomodulatory medications, biologicals, or surgery (pouch excision or diversion)
Combined dosing increases total peptide load and may alter the risk profile, particularly regarding interactions with other therapies
Most researchers run these combinations for 8 to 12 weeks, cycling peptides to prevent receptor desensitization while maintaining Retatrutide throughout